Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Clin Pharmacol Ther. 2021 Jan 1;110(4):975–985. doi: 10.1002/cpt.2135

Table 2.

Linear regression analysis of the relationship between respective wGRSs (European-ancestry specific, African-ancestry specific, predicted log-NMR calculated from the respective ancestry specific wGRSs, and a cross-ancestry specific) and log-transformed NMR in different ancestral populations in the PNAT2 and KIS3 clinical trials (i.e. training sets for AFR and EUR wGRSs). Values represent unique variance explained by the wGRS. P<0.001 unless otherwise indicated.

Variance uniquely explained by wGRS

Predictor AFR Training Set PNAT2+KIS3 (N=954) EUR Training Set PNAT2 (N=933) Merged AFR+EUR Training Set PNAT2+KIS3 (N=1887)
AFR wGRS 0.324 0.200 0.300
EUR wGRS 0.182 0.338 0.261
Predicted log-NMR (AFR or EUR wGRS) - - 0.359

Cross-ancestry wGRS 0.347 0.250 0.332